{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:37Z","timestamp":1791231457858,"version":"4.1.0"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Human papillomavirus 16 (HPV16) is a high-risk DNA tumour virus which is the primary causative agent of cervical cancer. Cell transformation arises from deregulated expression of the E6 and E7 oncogenes. E6 has been shown to bind a number of cellular proteins, including p53 and proteins containing a PDZ domain. This study reports the first RNA aptamers to E6. These have been employed as molecular tools to further investigate E6-p53 and E6-PDZ interactions. This study is focussed on two aptamers (termed F2 and F4) which induced apoptosis in cells derived from an HPV16-transformed cervical carcinoma. The molecules were able to inhibit the interaction between E6 and PDZ1 from Magi1, with F2 being the most effective inhibitor. Neither of the aptamers inhibited E6-p53 interaction or p53 degradation. This study shows the specificity of this approach and highlights the potential benefits of the E6 aptamers as potential therapeutic or diagnostic agents in the future.<\/jats:p>","DOI":"10.3390\/cancers6031553","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T11:00:50Z","timestamp":1406199650000},"page":"1553-1569","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein"],"prefix":"10.3390","volume":"6","author":[{"given":"Tamara","family":"Belyaeva","sequence":"first","affiliation":[{"name":"School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nicol","sequence":"additional","affiliation":[{"name":"School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Cesur","sequence":"additional","affiliation":[{"name":"School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Trav\u00e9","sequence":"additional","affiliation":[{"name":"UMR 7242 CNRS-Universit\u00e9 de Strasbourg, Ecole Sup\u00e9rieure de Biotechnologie,  Boulevard S\u00e9bastien Brant, Illkirch 67412, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-1795","authenticated-orcid":false,"given":"George","family":"Blair","sequence":"additional","affiliation":[{"name":"School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Stonehouse","sequence":"additional","affiliation":[{"name":"School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"Fauquet","year":"2004","journal-title":"Virology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Bosch","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study","volume":"11","author":"Quint","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1073\/pnas.92.5.1654","article-title":"Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis","volume":"92","author":"Jeon","year":"1995","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.2192","article-title":"Integration of high-risk human papillomavirus: A key event in cervical carcinogenesis?","volume":"212","author":"Pett","year":"2007","journal-title":"J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1128\/jvi.68.7.4262-4273.1994","article-title":"Inhibition of p53 DNA binding by human papillomavirus E6 proteins","volume":"68","author":"Lechner","year":"1994","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"key":"ref_11","first-page":"4620","article-title":"E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway","volume":"56","author":"Boyer","year":"1996","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2741\/2739","article-title":"Papillomavirus E6 and E7 proteins and their cellular targets","volume":"13","author":"Wells","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2741\/2664","article-title":"Structure and function of the papillomavirus E6 protein and its interacting proteins","volume":"13","author":"Liu","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.1128\/MCB.20.21.8244-8253.2000","article-title":"Human scribble (vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase","volume":"20","author":"Nakagawa","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1128\/JVI.74.20.9680-9693.2000","article-title":"Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1073\/pnas.94.21.11612","article-title":"Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the drosophila discs large tumor suppressor protein","volume":"94","author":"Kiyono","year":"1997","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1038\/sj.onc.1203906","article-title":"Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins","volume":"19","author":"Glaunsinger","year":"2000","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/sj.onc.1205668","article-title":"Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation","volume":"21","author":"Thomas","year":"2002","journal-title":"Oncogene"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1242\/jcs.00809","article-title":"Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes","volume":"116","author":"Watson","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1006\/jmbi.2000.3527","article-title":"HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions","volume":"296","author":"Ristriani","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.molcel.2006.01.024","article-title":"Structural and functional analysis of E6 oncoprotein: Insights in the molecular pathways of human papillomavirus-mediated pathogenesis","volume":"21","author":"Nomine","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virol.2008.12.037","article-title":"Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites","volume":"386","author":"Bodaghi","year":"2009","journal-title":"Virology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/jvi.63.3.1404-1407.1989","article-title":"Papillomavirus polypeptides E6 and E7 are zinc-binding proteins","volume":"63","author":"Barbosa","year":"1989","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/344467a0","article-title":"Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA","volume":"344","author":"Robertson","year":"1990","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cbpa.2005.06.011","article-title":"Aptamers as tools for target validation","volume":"9","author":"Blank","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrmicro1458","article-title":"Aptamers come of age\u2014At last","volume":"4","author":"Bunka","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/anie.200804643","article-title":"The Chemical Biology of Aptamers","volume":"48","author":"Mayer","year":"2009","journal-title":"Ange Chem. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.274.37.26369","article-title":"Antiproliferative activity of G-rich oligonucleotides correlates with protein binding","volume":"274","author":"Bates","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1200\/jco.2009.27.15_suppl.7019","article-title":"Randomized phase II trial of the nucleolin targeting aptamer AS1411 combined with high-dose cytarabine in relapsed\/refractory acute myeloid leukemia (AML)","volume":"27","author":"Stuart","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbrc.2011.01.044","article-title":"Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7 oncoprotein","volume":"405","author":"Nicol","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e64781","DOI":"10.1371\/journal.pone.0064781","article-title":"An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein","volume":"8","author":"Nicol","year":"2013","journal-title":"PLoS One"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-065X.2011.01052.x","article-title":"RIG-I-like receptors: Cytoplasmic sensors for non-self RNA","volume":"243","author":"Kato","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1261\/rna.161006","article-title":"Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus","volume":"12","author":"Ellingham","year":"2006","journal-title":"RNA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1038\/sj.onc.1203134","article-title":"HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6","volume":"18","author":"Pim","year":"1999","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/JVI.73.9.7297-7307.1999","article-title":"Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells","volume":"73","author":"Liu","year":"1999","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/jvi.70.7.4509-4516.1996","article-title":"High-risk human papillomavirus E6 protein has two distinct binding sites within p53,of which only one determines degradation","volume":"70","author":"Li","year":"1996","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jmb.2011.01.015","article-title":"The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6","volume":"406","author":"Charbonnier","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/nar\/27.6.1561","article-title":"Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'F-groups using a mutant T7 RNA polymerase (RNAP)","volume":"27","author":"Padilla","year":"1999","journal-title":"Nucl. Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/nar\/gkl318","article-title":"Affinity of molecular interactions in the bacteriophage phi29 DNA packaging motor","volume":"34","author":"Robinson","year":"2006","journal-title":"Nucl. Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/jvi.61.4.962-971.1987","article-title":"Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines","volume":"61","author":"Baker","year":"1987","journal-title":"J. Virol."},{"key":"ref_44","first-page":"361","article-title":"Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines","volume":"119","author":"Yee","year":"1985","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/jid.2013.399","article-title":"IL-17A RNA aptamer: Possible therapeutic potential in some cells, more than we bargained for in others?","volume":"134","author":"Doble","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.virol.2013.08.015","article-title":"Identification of RNA aptamers that internalize into HPV-16 E6\/E7 transformed tonsillar epithelial cells","volume":"446","author":"Gourronc","year":"2013","journal-title":"Virology"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/6\/3\/1553\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:14:00Z","timestamp":1760217240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/6\/3\/1553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,9]]}},"alternative-id":["cancers6031553"],"URL":"https:\/\/doi.org\/10.3390\/cancers6031553","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}